Streptozocin-based chemotherapy in patients with advanced pancreatic neuroendocrine tumors

被引：0
|
作者：
Pavel, Marianne E.
Dilz, Lisa-Marie
Denecke, Timm
Steffen, Ingo
Prasad, Vikas
Pape, Ulrich-Frank
Pascher, Andreas
Heetfeld, Maximilian
Wiedenmann, Bertram
机构：
[1] Charite, Dept Internal Med, D-13353 Berlin, Germany
[2] Charite Univ Med Ctr, Dept Radiol, Berlin, Germany
[3] Charite Univ Med Ctr, Dept Nucl Med, Berlin, Germany
[4] Charite, Dept Gen Visceral Vasc & Thorac Surg, D-13353 Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.295
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
295
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Systemic Therapy for Advanced Pancreatic Neuroendocrine Tumors: An Update
    Reidy-Lagunes, Diane L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (06): : 777 - 783
  • [42] Sunitinib In Advanced, Well Differentiated Pancreatic Neuroendocrine Tumors
    Deeks, Emma D.
    Raymond, Eric
    BIODRUGS, 2011, 25 (05) : 307 - 316
  • [43] Sunitinib for the Treatment of Advanced, Progressive Pancreatic Neuroendocrine Tumors
    Raymond, E.
    Seitz, J. F.
    Bang, Y. J.
    Borbath, I
    Lombard-Bohas, C.
    Valle, J.
    Patyna, S.
    Lu, D. R.
    Chao, R.
    Raoul, J. L.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 54 - 55
  • [44] Emerging treatment modalities for advanced pancreatic neuroendocrine tumors
    Sindoni, Alessandro
    Fama, Fausto
    Gioffre-Florio, Maria
    Baldari, Sergio
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2016, 15 (04): : 563 - 564
  • [45] Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity
    Antonodimitrakis, Pantelis Clewemar
    Sundin, Anders
    Wassberg, Cecilia
    Granberg, Dan
    Skogseid, Britt
    Eriksson, Barbro
    NEUROENDOCRINOLOGY, 2016, 103 (3-4) : 345 - 353
  • [46] Everolimus in Advanced Pancreatic Neuroendocrine Tumors: The Clinical Experience
    Yao, James C.
    Phan, Alexandria T.
    Jehl, Valentine
    Shah, Gaurav
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2013, 73 (05) : 1449 - 1453
  • [47] Streptozocin and 5-fluorouracil treatment of pancreatic neuroendocrine tumors: efficacy, toxicity and prognostic factors
    Eriksson, B.
    Sundin, A.
    Wassberg, C.
    Skogseid, B.
    Antonodimitrakis, P.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 : S145 - S145
  • [48] CHROMOGRANIN A AND NEURON-SPECIFIC ENOLASE AS BIOMARKERS FOR EVEROLIMUS EFFICACY IN PATIENTS WITH ADVANCED PANCREATIC NEUROENDOCRINE TUMORS AFTER FAILURE OF CHEMOTHERAPY
    Yao, J.
    Van Cutsem, E.
    Lombard-Bohas, C.
    Baudin, E.
    Kvols, L.
    Rougier, P.
    Ruszniewski, P.
    O'Dorisio, T.
    Hobday, T.
    Shah, M.
    Cadiot, G.
    Hoosen, S.
    St Peter, J.
    Cherfi, A.
    Wiedenmann, B.
    ANNALS OF ONCOLOGY, 2009, 20 : 10 - 10
  • [49] Metastatic pancreatic neuroendocrine tumors and chemotherapy: evidences and perspectives - Reply
    Salazar, Ramon
    MEDICINA CLINICA, 2007, 128 (09): : 357 - 358
  • [50] The Efficacy and Safety of Sunitinib in Patients With Advanced Well-differentiated Pancreatic Neuroendocrine Tumors
    Raymond, Eric
    Kulke, Matthew
    Qin, Shukui
    Schenker, Michael
    Cubillo, Antonio
    Lou, Wenhui
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Xu, Jianming
    Racz, Karoly
    Croitoru, Adina
    Khasraw, Mustafa
    Sedlackova, Eva
    Borbath, Ivan
    Ruff, Paul
    Oberstein, Paul
    Ito, Tetsuhide
    Fernandez, Kathrine
    Rosbrook, Brad
    Fazio, Nicola
    PANCREAS, 2017, 46 (03) : 435 - 435
12345